Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • NeuroVive Pharmaceutical A completes private placement

    NeuroVive Pharmaceutical AB (SSE:NVP), Lund, Sweden Business: Neurology Date completed: 2015-02-20 Type: Private placement Raised: SEK65 million ($7.7 million) Shares: 1.3 million Price: SEK50 Shares after offering: 29.…

    Published on 2/23/2015
  • Pocared completes venture financing

    Pocared Diagnostics Ltd., Rehovot, Israel Business: Diagnostic Date completed: 2015-02-17 Type: Venture financing Raised: Not disclosed Note: The company closed $15 million in milestone-based funding.

    Published on 2/23/2015
  • Quantum Genomics Corp completes private placement

    Quantum Genomics Corp. (Euronext:ALQGC), Massy, France Business: Cardiovascular Date completed: 2015-02-17 Type: Private placement Raised: EUR11.2 million ($12.8 million) Shares: 1.8 million Price: EUR6.30 Shares after …

    Published on 2/23/2015
  • Signal Genetics Inc completes follow-on

    Signal Genetics Inc. (NASDAQ:SGNL), New York, N.Y. Business: Pharmacogenetics, Diagnostic Date completed: 2015-02-17 Type: Follow-on Raised: $9 million Shares: 3.2 million Price: $2.80 Shares after offering: 7 million …

    Published on 2/23/2015
  • Vaxin completes venture financing

    Vaxin Inc., Rockville, Md. Business: Infectious Date completed: 2015-02-17 Type: Venture financing Raised: $16 million Investors: Novartis Venture Funds; HealthCap; Truffle Capital; Redmont Venture Partners

    Published on 2/23/2015
  • Achillion Pharmaceuticals Inc financial update

    Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Date announced: 2015-02-18 Note: Achillion raised $18.5 million through the sale of 1.8 million shares at $10.25 to cover the …

    Published on 2/23/2015
  • Atara Biotherapeutics Inc financial update

    Atara Biotherapeutics Inc. (NASDAQ:ATRA), Brisbane, Calif. Business: Cancer, Renal Date announced: 2015-02-18 Note: Atara raised $9.2 million through the sale of 509,025 shares at $18 to cover the overallotment from its…

    Published on 2/23/2015
  • AtheroNova Inc financial update

    AtheroNova Inc. (OTCBB:AHRO), Irvine, Calif. Business: Cardiovascular Date announced: 2015-02-19 Note: AtheroNova is in default on 2.5% senior secured convertible notes, 6% senior secured convertible notes and 8% senior…

    Published on 2/23/2015
  • Bessemer Venture Partners financial update

    Bessemer Venture Partners, Menlo Park, Calif. Business: Finance Date announced: 2015-02-18 Note: Bessemer Venture Partners raised $1.6 billion for its BVP IX fund, which the firm will invest in several sectors, …

    Published on 2/23/2015
  • BTG pl financial update

    BTG plc (LSE:BTG), London, U.K. Business: Neurology, Cardiovascular, Cancer Date announced: 2015-02-19 Note: BTG is establishing a level I ADR program on the OTC market. Each ADR will represent one ordinary share. …

    Published on 2/23/2015
  • Harvard Apparatus Regenerative Technology Inc financial update

    Harvard Apparatus Regenerative Technology Inc. (NASDAQ:HART), Holliston, Mass. Business: Gene/Cell therapy Date announced: 2015-02-18 Note: Harvard Apparatus raised $472,500 through the sale of 270,000 shares at $1.75 …

    Published on 2/23/2015
  • Idera Pharmaceuticals Inc financial update

    Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Date announced: 2015-02-19 Note: Idera raised $11.3 million through the sale of 3 million shares at $3.75 to cover the …

    Published on 2/23/2015
  • Invitae Corp financial update

    Invitae Corp. (NYSE:NVTA), San Francisco, Calif. Business: Diagnostic Date announced: 2015-02-18 Note: Invitae raised $15.2 million through the sale of 952,500 shares at $16 to cover the overallotment from its Feb.11 …

    Published on 2/23/2015
  • Lineagen financial update

    Lineagen Inc., Salt Lake City, Utah Business: Diagnostic, Genomics Date announced: 2015-02-18 Note: Lineagen raised $12.2 million in a second and final tranche of a series C round, bringing the total amount raised in …

    Published on 2/23/2015
  • RedHill Biopharma Ltd financial update

    RedHill Biopharma Ltd. (Tel Aviv:RDHL; NASDAQ:RDHL), Ramat-Gan, Israel Business: Drug delivery, Gastrointestinal Date announced: 2015-02-18 Note: Redhill raised 1.9 million through the sale of 150,000 ADSs at $12.50 to …

    Published on 2/23/2015
  • Transition Therapeutics Inc financial update

    Transition Therapeutics Inc. (TSX:TTH; NASDAQ:TTHI), Toronto, Ontario Business: Endocrine/Metabolic, Neurology Date announced: 2015-02-18 Note: Transition raised $3 million through the sale of 461,538 shares at $6.50 to…

    Published on 2/23/2015
  • Ultragenyx Pharmaceutical Inc financial update

    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Novato, Calif. Business: Musculoskeletal, Endocrine/Metabolic Date announced: 2015-02-17 Note: Ultragenyx raised $24.3 million through the sale of 450,000 shares at $54 to …

    Published on 2/23/2015
  • VolitionRx Ltd financial update

    VolitionRx Ltd. (NYSE-M:VNRX), Singapore Business: Diagnostic Date announced: 2015-02-17 Note: VolitionRx raised $1.3 million through the sale of 343,383 shares at $3.75 to cover the overallotment from its Feb. 6 follow…

    Published on 2/23/2015
  • WuXi PharmaTech Inc financial update

    WuXi PharmaTech Inc. (NYSE:WX), Shanghai, China Business: Supply/Service Date announced: 2015-02-17 Note: WuXi secured a loan facility for up to $165 million from a consortium of banks in Asia led by Citibank. The …

    Published on 2/23/2015
  • Angle pl proposes private placement

    Angle plc (LSE:AGL), Guildford, U.K. Business: Supply/Service, Diagnostic Date announced: 2015-02-16 Type: Private placement To be raised: Up to 1.5 million ($2.3 million) Shares: 2.3 million Price: 65p Shares …

    Published on 2/23/2015
  • Arcadia proposes IPO

    Arcadia Biosciences Inc., Davis, Calif. Business: Agbio/Environmental Date announced: 2015-02-17 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: Credit Suisse; JPMorgan; Piper Jaffray …

    Published on 2/23/2015
  • Advanced Accelerator Applications withdraws IPO

    Advanced Accelerator Applications S.A., Saint Genis Pouilly, France Business: Diagnostic, Cancer Date announced: 2015-02-18 Type: IPO Underwriters: Citigroup; Jefferies; Canaccord; JMP Securities Note: Advanced …

    Published on 2/23/2015
  • NeuroVive Asia completes venture financing

    NeuroVive Pharmaceutical Asia Inc., Business: Cardiovascular, Neurology Date completed: 2015-02-11 Type: Venture financing Raised: $3.3 million Investors: Foundation Asia Pacific; NeuroVive Pharmaceutical AB; and other…

    Published on 2/16/2015
  • RedHill completes follow-on

    RedHill Biopharma Ltd. (Tel Aviv:RDHL; NASDAQ:RDHL), Ramat-Gan, Israel Business: Drug delivery, Gastrointestinal Date completed: 2015-02-10 Type: Follow-on Raised: $12.5 million Shares: 1 million Price: $12.50 Shares …

    Published on 2/16/2015
  • TherapeuticsMD completes follow-on

    TherapeuticsMD Inc. (NYSE-M:TXMD), Boca Raton, Fla. Business: Endocrine/Metabolic, Genitourinary Date completed: 2015-02-11 Type: Follow-on Raised: $55 million Shares: 13.6 million Price: $4.05 Shares after offering: …

    Published on 2/16/2015

< Previous   1  2  3  4  5  6  7  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993